WaveMan · Form 4
Detheux Michel insider trades
> Search tickers & screens ⌘K
LIVE

Detheux Michel insider trades

Detheux Michel has filed 24 Form 4s with the SEC that we hold, for ITOS (Chief Executive Officer, Director) and Vor Biopharma Inc. (VOR) (Director). Across all of them we count 0 purchases worth $0 and 45 sales worth $9.2M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 13,646 shares of ITOS worth $602.5K, dated 2021-12-21. The first filing on our record is dated 2021-08-25 and the latest 2026-06-12.

ITOS

Chief Executive Officer, Director · 23 filings · 45 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-08-23S, sale reported on Form 47,499$210.4K2021-08-25
2021-08-24S, sale reported on Form 4225$6.4K2021-08-25
2021-08-25S, sale reported on Form 4861$24.1K2021-08-25
2021-08-27S, sale reported on Form 48,248$232.3K2021-08-31
2021-08-30S, sale reported on Form 42,322$65.0K2021-08-31
2021-08-31S, sale reported on Form 44,093$115.1K2021-08-31
2021-09-01S, sale reported on Form 48,684$245.8K2021-09-03
2021-09-02S, sale reported on Form 4550$16.2K2021-09-03
2021-09-02S, sale reported on Form 411,018$318.5K2021-09-03
2021-09-23S, sale reported on Form 45,322$149.9K2021-09-27
2021-09-24S, sale reported on Form 41,089$30.5K2021-09-27
2021-10-15S, sale reported on Form 41,635$45.8K2021-10-19
2021-10-19S, sale reported on Form 4201$5.6K2021-10-19
2021-10-21S, sale reported on Form 4196$5.5K2021-10-25
2021-11-01S, sale reported on Form 481$2.3K2021-11-03
2021-11-02S, sale reported on Form 414,391$409.0K2021-11-03
2021-11-03S, sale reported on Form 46,085$175.8K2021-11-03
2021-11-23S, sale reported on Form 414,500$523.2K2021-11-24
2021-12-20S, sale reported on Form 49,111$400.3K2021-12-22
2021-12-21S, sale reported on Form 45,580$251.4K2021-12-22
2021-12-21S, sale reported on Form 413,646$602.5K2021-12-22
2021-12-22S, sale reported on Form 41,514$67.1K2021-12-22
2021-12-22S, sale reported on Form 49,493$430.7K2021-12-22
2021-12-22S, sale reported on Form 45,007$223.4K2021-12-22
2021-12-22S, sale reported on Form 4149$6.7K2021-12-22
2022-01-25S, sale reported on Form 410,088$357.6K2022-01-26
2022-01-25S, sale reported on Form 44,412$159.8K2022-01-26
2022-02-23S, sale reported on Form 4544$19.2K2022-02-24
2022-02-23S, sale reported on Form 413,956$478.7K2022-02-24
2022-03-22S, sale reported on Form 45,822$194.7K2022-03-22
2022-03-22S, sale reported on Form 41,548$56.5K2022-03-22
2022-03-22S, sale reported on Form 41,159$40.8K2022-03-22
2022-03-22S, sale reported on Form 49,908$338.0K2022-03-22
2022-04-18S, sale reported on Form 433$1.1K2022-04-19
2022-04-18S, sale reported on Form 411,467$365.5K2022-04-19
2025-06-04S, sale reported on Form 48,400$84.8K2025-06-06
2025-06-04S, sale reported on Form 443,883$443.2K2025-06-06
2025-06-05S, sale reported on Form 48,400$85.3K2025-06-06
2025-06-05S, sale reported on Form 443,882$445.4K2025-06-06
2025-06-06S, sale reported on Form 443,882$448.0K2025-06-06
2025-06-06S, sale reported on Form 48,400$85.8K2025-06-06
2025-06-09S, sale reported on Form 48,400$84.3K2025-06-11
2025-06-09S, sale reported on Form 443,882$440.1K2025-06-11
2025-06-10S, sale reported on Form 48,400$84.2K2025-06-11
2025-06-10S, sale reported on Form 443,883$439.7K2025-06-11

Vor Biopharma Inc. (VOR)

Director · 2 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1816196) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms